A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.
Autor principal: | Haque, Mushfiqul |
---|---|
Outros Autores: | Kabir, Md. Tanvir |
Formato: | Project report |
Idioma: | English |
Publicado em: |
BRAC University
2019
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/11070 |
Registos relacionados
-
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Por: Ishrat, Nowshin
Publicado em: (2024) -
Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
Por: Alam, Badrul, et al.
Publicado em: (2016) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Flora, Sanzida Alam
Publicado em: (2024) -
A review on artemisinin based combination therapy for the treatment of Malaria
Por: Chowdhury, Amina Ferdous
Publicado em: (2020) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Por: Alim, Abdul
Publicado em: (2023)